Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Macrogenics (MGNX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Macrogenics (MGNX) over the last 9 years, with Q3 2025 value amounting to $63.3 million.

  • Macrogenics' Shares Outstanding (Diluted Average) rose 66.46% to $63.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.3 million, marking a year-over-year increase of 66.46%. This contributed to the annual value of $62.6 million for FY2024, which is 111.74% up from last year.
  • Latest data reveals that Macrogenics reported Shares Outstanding (Diluted Average) of $63.3 million as of Q3 2025, which was up 66.46% from $63.1 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Shares Outstanding (Diluted Average) ranged from a high of $63.3 million in Q3 2025 and a low of $57.2 million during Q1 2021
  • In the last 5 years, Macrogenics' Shares Outstanding (Diluted Average) had a median value of $61.9 million in 2023 and averaged $61.7 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 2009.23% in 2021, then surged by 47.42% in 2022.
  • Quarter analysis of 5 years shows Macrogenics' Shares Outstanding (Diluted Average) stood at $59.9 million in 2021, then grew by 2.48% to $61.4 million in 2022, then grew by 0.81% to $61.9 million in 2023, then grew by 1.12% to $62.6 million in 2024, then grew by 1.06% to $63.3 million in 2025.
  • Its last three reported values are $63.3 million in Q3 2025, $63.1 million for Q2 2025, and $63.0 million during Q1 2025.